Patients receiving omega-3s ( group 1 ) had significantly lower levels of vitreal VEGF-A ( 141.11 61.89 pg/mL ) when compared with group 2 ( 626.09 279.27 pg/mL ; P = .036 ) and group 3 ( 735.48 216.43 pg/mL ; P = .013 ) , but similar levels to group 4 ( 235.81 33.99 pg/mL ; P = .215 ) .